Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
Aim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) ste...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of Medical Physics |
Subjects: | |
Online Access: | http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=4;spage=251;epage=257;aulast=Ramachandran |
id |
doaj-cc513ce504b741c4b2ce82f3571337e3 |
---|---|
record_format |
Article |
spelling |
doaj-cc513ce504b741c4b2ce82f3571337e32020-11-24T23:37:20ZengWolters Kluwer Medknow PublicationsJournal of Medical Physics0971-62031998-39132017-01-0142425125710.4103/jmp.JMP_132_16Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapyPrabhakar RamachandranAbdulrahman TajaldeenDavid TaylorDerrick WanigaratneKarl RoozenMoshi GesoAim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) stereotactic ablative radiotherapy (SABR) treatment plans. Materials and Methods: Twenty-five patients with a varied diagnosis of lung, spine, sacrum, sternum, ribs, scapula, and femur undergoing SABR were selected for this study. Pre-treatment QA was performed for all the patients using ionization chamber and film dosimetry. Measurements were also carried out on an AC phantom. The planned and measured doses from the AC device and EBT3 films were compared using four different gamma criteria: 2%/2 mm, 3%/2 mm, 3%/1 mm, and 3%/3 mm. Results: The mean gamma passing rates at 3%/3 mm for all non-spine SABR cases were 98.79 ± 0.96 and 99.27 ± 1.03 with AC and films, respectively. The mean passing rates at 3%/2 mm for AC and films were 98.76 ± 0.42 and 99.43 ± 0.27 respectively for spine VMAT SABR, and 87.15 ± 2.45 and 99.79 ± 0.14 respectively for spine IMRT SABR. In the case of spine tumors, the gamma criterion was tightened due to the proximity of spinal cord to the planning target volume. Our results show that AC provides good results for all VMAT SABR plans. Conclusion: The AC results at 3%/3 mm were in good agreement with film dosimetry for most cases. We observed a significant reduction in QA time on using AC for SABR QA. This study showed that AC results are comparable to film dosimetry for all studied sites except for spine IMRT SABR.http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=4;spage=251;epage=257;aulast=RamachandranArcCHECKEBT3 filmsstereotactic ablative radiotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Prabhakar Ramachandran Abdulrahman Tajaldeen David Taylor Derrick Wanigaratne Karl Roozen Moshi Geso |
spellingShingle |
Prabhakar Ramachandran Abdulrahman Tajaldeen David Taylor Derrick Wanigaratne Karl Roozen Moshi Geso Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy Journal of Medical Physics ArcCHECK EBT3 films stereotactic ablative radiotherapy |
author_facet |
Prabhakar Ramachandran Abdulrahman Tajaldeen David Taylor Derrick Wanigaratne Karl Roozen Moshi Geso |
author_sort |
Prabhakar Ramachandran |
title |
Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy |
title_short |
Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy |
title_full |
Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy |
title_fullStr |
Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy |
title_full_unstemmed |
Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy |
title_sort |
evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Medical Physics |
issn |
0971-6203 1998-3913 |
publishDate |
2017-01-01 |
description |
Aim: The aim of this study is to assess the use of ArcCHECK (AC) as an alternative method to replace film dosimetry for pre-treatment quality assurance (QA) of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT) stereotactic ablative radiotherapy (SABR) treatment plans. Materials and Methods: Twenty-five patients with a varied diagnosis of lung, spine, sacrum, sternum, ribs, scapula, and femur undergoing SABR were selected for this study. Pre-treatment QA was performed for all the patients using ionization chamber and film dosimetry. Measurements were also carried out on an AC phantom. The planned and measured doses from the AC device and EBT3 films were compared using four different gamma criteria: 2%/2 mm, 3%/2 mm, 3%/1 mm, and 3%/3 mm. Results: The mean gamma passing rates at 3%/3 mm for all non-spine SABR cases were 98.79 ± 0.96 and 99.27 ± 1.03 with AC and films, respectively. The mean passing rates at 3%/2 mm for AC and films were 98.76 ± 0.42 and 99.43 ± 0.27 respectively for spine VMAT SABR, and 87.15 ± 2.45 and 99.79 ± 0.14 respectively for spine IMRT SABR. In the case of spine tumors, the gamma criterion was tightened due to the proximity of spinal cord to the planning target volume. Our results show that AC provides good results for all VMAT SABR plans. Conclusion: The AC results at 3%/3 mm were in good agreement with film dosimetry for most cases. We observed a significant reduction in QA time on using AC for SABR QA. This study showed that AC results are comparable to film dosimetry for all studied sites except for spine IMRT SABR. |
topic |
ArcCHECK EBT3 films stereotactic ablative radiotherapy |
url |
http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=4;spage=251;epage=257;aulast=Ramachandran |
work_keys_str_mv |
AT prabhakarramachandran evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy AT abdulrahmantajaldeen evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy AT davidtaylor evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy AT derrickwanigaratne evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy AT karlroozen evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy AT moshigeso evaluationandperformanceofarccheckandfilmusinggammacriteriainpretreatmentqualityassuranceofstereotacticablativeradiotherapy |
_version_ |
1725520275890503680 |